Objective: To describe events leading to development of a professionwide consensus definition of medication therapy management (MTM) and attendant programs and services and present the document (definition, services, and program requirements) resulting from the process.
W hat would be the outcomes if pharmacists actively worked with patients and their physicians to identify and manage medication therapy for chronic diseases? Imagine the possibilities if pharmacists and other members of the health care team shared clinical data and worked from the same medical records. Could patient outcomes be improved if pharmacists took the initiative to re-engineer their practices and provide patient-centered services in a collaborative manner? What advanced service delivery options will pharmacists offer as they seek to add value to the process and outcomes of care?
These are key questions that must be addressed as innovative medication therapy management (MTM) services are implemented and expanded in the health care system in the coming months and years. While this process will be driven to some degree by the Medicare Part D prescription drug benefit taking effect in January 2006, MTM services are also increasingly valued by employers and other payers whose primary interests lie in the well-being of the employees working in their factories and offices and dependent family members covered under company policies. [1] [2] [3] [4] [5] [6] [7] Following the late 2003 passage of the Medicare Prescription Drug Improvement and Modernization Act (MMA), many organizations and opinion leaders within pharmacy floated "definitions" for MTM and began conceptualizing programs that would provide such services under the Medicare Part D benefit. One of the common threads in the ensuing discussions was an imperative to clarify the issue and promptly provide a consensus MTM definition that could provide meaningful guidance to the Centers for Medicare and Medicaid Services (CMS) as regulations for MMA were promulgated. The expectations from within the pharmacy profession also were that this definition should be very comprehensive, one that would encompass MTM programs and services offered in all types of settings and situations. This posed a challenging dilemma for uniting a profession around the new service delivery model in a very short amount of time.
Objectives
This article describes the events leading to development of a professionwide consensus definition of MTM and presents the document (definition and program criteria) resulting from the process.
Vision and Plan for MTM Services
Understanding the dilemma and the imperatives involved in this situation, the American Pharmacists Association (APhA) made an early decision to take the lead and play a coordinating role in assisting the profession in defining MTM services. APhA made several commitments related to this role, specifically that it would seek input from all practice segments, remain transparent in the process, ensure that the profession defined a practical and viable framework, establish a consistent platform for communication about the definition and regulatory language change, and pursue efforts for effectively operationalizing MTM services.
To address the formidable challenge of achieving professional consensus on a practical and viable MTM definition, APhA established three core objectives: 1. To ensure that the MTM definition was inclusive of the types of services and programs that are or can be provided in diverse pharmacy practice segments 2. To include in the MTM document a description of examples of services that can be implemented by a majority of pharmacy practitioners 3. To engage all national professional pharmacy organizations in development of a consensus MTM definition that all would support and use as they worked for favorable regulatory language and needed changes in the health care delivery system APhA first focused on the process through which a consensus definition could be developed. The Pharmacy Practice Activity Classification (PPAC) represented a previously achieved professional consensus on such a scale, and the PPAC also provided a mechanism for mapping the MTM definition components to recognized pharmacy practice patient care activities. As a result, the decision was made to use the PPAC as the common reference point for starting and keeping the consensus-building effort on track. A Donabedian approach (structure, process, outcomes) was envisioned and created in April 2004 to describe the process (see Figure 1) .
To successfully address all three core objectives and provide a starting point for 11 national pharmacy organizations to begin developing a consensus definition, APhA strongly believed that a working group of pharmacists from diverse backgrounds with an extensive knowledge of practice and the health care market (as it related to medication use) would be needed. Within APhA's leadership structure a relatively diverse group was already present, the APhA Strategic and Tactical 
MTM Services Working Group Activities
The MTM Services Working Group (Table 1) Participants were invited to provide any materials they thought would be relevant beforehand.
Following a May 2 roundtable discussion in which each participant was asked to share his or her vision for MTM services, the group had a goal on May 3 of ensuring that all participants understood the perspectives that had been offered by all other members. The day began with a legislative update, a vision for improving medication therapy across the country, and a proposed approach for achieving that vision. Documents distributed before the meeting were reviewed and discussed, including the PPAC categories and the Pharmacist Provider Coalition's (PPC) Essential Principles of Medication Therapy Management.
The afternoon session included an in-depth dialogue about convergence of the clinical and business case scenarios for various MTM service delivery options in various practice settings. Using a "round the table" format, participants shared their perspectives, and the day concluded with the entire group appearing to be united around several core issues.
On May 4, with the collective group perspectives known to all, the MTM Services Working Group began the process of drafting an MTM services definition. This definition was later crosswalked with the PPAC to ensure consistency. Through tireless efforts of group members over the following 2 weeks, the draft definition was refined and completed through e-mail and telephone communications. The draft definition served as the starting point during the next phase of consensus building, involving 11 national pharmacy organizations. (1) MTM is a distinct service or group of services that can occur in conjunction with or independent of the provision of a drug product, (2) MTM encompasses a broad range of professional activities and responsibilities, and (3) MTM programs should include a core set of considerations to provide value to key stakeholders in the health care delivery system.
Professionwide Consensus Conference
Following the presentations, each organization was asked to provide perspectives on MTM services in an effort to ensure that all participants were fully informed about the entire scope of issues. The ensuing dialogue involved a wide range of topics across the spectrum of pharmacy practice. Universal agreement was achieved quickly that the definition needed to be broad, that the profession needed to set the standards that a provider must meet when delivering the service, and that all licensed pharmacists should be able to provide these services at some level. The afternoon was spent revising the draft definition. Consensus was on the horizon, but further work was needed as the meeting ended. The participants committed to continuing the work after the meeting.
Achieving Consensus
Now that 11 national organizations had a revised draft definition, the goal was to develop language that was acceptable to every organization. Achieving consensus with such organizational diversity presented a daunting challenge but in the end would add immeasurable strength to the final document. Each of the organizations contributed extensive staff and volunteer time during the ensuing weeks to circulate, comment on, and continue to refine the definition in an effort to achieve consensus. Through several teleconferences and volumes of e-mail and telephone communications, the participants from each of the respective organizations finally agreed upon language that could be forwarded for each organization's formal approval. By July 27, 2004, approval for the consensus definition (Appendix I) had been received from chief executives of all 11 organizations (Table 2) .
Creating a Preferred Future
Effective management of medication therapy requires a dedicated health care team whose members-including physicians, pharmacists, nurses, and others-collaborate to ensure that patients understand their condition, level of risk, diagnostic results, and treatment and goals, as well as comprehend the amount of control they personally exert over their condition and its outcomes. Pharmacists are in a prime position to assure the success of collaborative practice efforts because of their accessibility to patients and physicians, access to resources needed to provide an advanced level of care, information management capabilities, motivation to expand care, and education and training ideal for providing patient-focused MTM services.
A significant number of contemporary research efforts to date have demonstrated the value that pharmacists can add in the health care delivery system. These include empowering patients, increasing collaboration, enhancing safety, improving outcomes, and reducing total costs for care over time. [1] [2] [3] [4] [5] [6] [7] This also coincides with a great transformational wave that is underway in the pharmacy profession as pharmacists increasingly add more clinical service delivery components to their practices. Through the extraordinary efforts of the numerous organizations and participants during the spring and summer of 2004, the MTM Services Definition is one that is applicable within diverse pharmacy practice segments, whose services are feasible for a majority of practitioners to implement, and whose elements are supported by a professionwide consortium of 11 national professional pharmacy organizations. While this is a historic achievement for the profession, it is also just the first step on a journey to find the best ways to effectively deliver MTM services to the patients we serve.
